Ticker	Volume	Price	Price Delta
DJIA	15,387.60	+52.30	0.34%
S&P 500	1,669.16	+2.87	0.17%
Nasdaq	3,502.12	+5.69	0.16%

Ticker

Volume

Price

Price Delta

DJIA

15,387.60

+52.30

0.34%

S&P 500

1,669.16

+2.87

0.17%

Nasdaq

3,502.12

+5.69

0.16%

Ticker	Volume	Price	Price Delta
STOXX 50	2,816.37	-5.28	-0.19%
FTSE 100	6,815.82	+11.95	0.18%
DAX	8,471.54	-0.66	-0.01%

Ticker

Volume

Price

Price Delta

STOXX 50

2,816.37

-5.28

-0.19%

FTSE 100

6,815.82

+11.95

0.18%

DAX

8,471.54

-0.66

-0.01%

Ticker	Volume	Price	Price Delta
Nikkei	15,627.30	+246.24	1.60%
Hang Seng	23,261.10	-105.29	-0.45%
S&P/ASX 200	5,165.37	-14.69	-0.28%

Ticker

Volume

Price

Price Delta

Nikkei

15,627.30

+246.24

1.60%

Hang Seng

23,261.10

-105.29

-0.45%

S&P/ASX 200

5,165.37

-14.69

-0.28%

Russia’s Rusnano, Domain Invest $40 Million in San Diego’s CoDa

By Ksenia Galouchko - 2012-07-24T17:00:00Z

Russian Nanotechnologies, the state- run technology holding, and Domain Associates, a U.S. venture fund, are investing about $40 million in San Diego-based biopharmaceutical company CoDa Therapeutics.

The deal is the first joint investment between Domain Associates and Rusnano, as the company is known, according to an e-mailed press release. Domain is an investor in CoDa. Rusnano will invest through a subsidiary.

Rusnano teamed up with Domain Associates in March to invest $760 million in U.S. life science companies and build facilities in Russia. The companies plan to invest in about 20 U.S.-based health-care technology companies involved in pharmaceuticals, biotechnology and medical devices, the Moscow-based company said in March.

To contact the reporter on this story: Ksenia Galouchko in New York at kgalouchko1@bloomberg.net

To contact the editors responsible for this story: Gavin Serkin at gserkin@bloomberg.net; Frank Connelly at fconnelly@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.